Medical News

RSS

Immunocellular Therapeutics' pilot study can help in early cancer detection

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today results from its pilot study evaluating the cancer detection abilities of one of its lead monoclonal antibody product candidates, ICT-109. Data from this study demonstrated that ICT-109 had a statistically significant ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets.

30 Sep 2009

Expression Analysis announces grants for research into complex diseases

Expression Analysis, Inc., the industry’s leading provider of genomic services for clinical trials and research, announced today a family of grants focused on one unifying purpose: To accelerate research into complex diseases and aid researchers in unlocking biological mysteries.

30 Sep 2009

CPM Marketing Group launches New Movers marketing program for hospitals and health systems

CPM Marketing Group Inc., the market leader for healthcare customer relationship management (CRM) and strategic marketing solutions, today announced the launch of a multimedia New Movers marketing program, which enables hospitals and health systems to more effectively and efficiently identify, communicate and establish relationships with new residents to its surrounding communities.

30 Sep 2009

New treatment for chronic sinusitis from Summit Ear, Nose & Throat

Summit Ear, Nose & Throat is the first in the area to offer an exciting new treatment for chronic sinusitis (CRS) in an outpatient setting called FinESS™ Sinus Treatment. FinESS is a new balloon sinuplasty technique that is less invasive than traditional sinus surgery and that breaks the cycle of chronic sinusitis with immediate relief and lasting results.

30 Sep 2009

Post Baccalaureate Premedical Program to begin in January 2010

Keck Graduate Institute (KGI) has established a Post Baccalaureate Premedical Program (PBPM), scheduled to begin in January 2010, for those with an undergraduate degree in science or engineering who are interested in enhancing their skills before applying to medical school.

30 Sep 2009

Global use of biofuels expected to double by 2015

Despite a number of key issues such as land use and competition for feedstocks supplies for traditional food and feed uses, global use of biofuels is excepted to more than double from 2009 to 2015, according to a new global analysis released today by Hart's Global Biofuels Center.

30 Sep 2009

Omega-3 fatty acids prevent and slow age-related macular degeneration

Researchers are seeing more benefits of omega-3 fatty acids (omega-3s), such as their ability to help prevent and slow age-related macular degeneration (AMD), an eye disease that is the leading cause of severe vision loss in older people.

30 Sep 2009

Alliance Data, PDS sign multi-year agreement for patient financing and marketing services

Alliance Data Systems Corporation (NYSE: ADS), a leading provider of loyalty and marketing solutions derived from transaction-rich data, today announced it has signed a multi-year agreement with business support services provider, Pacific Dental Services (PDS) to provide patient financing and marketing services via a private label credit card program for dental and orthodontic procedures, performed in affiliated dental practices.

30 Sep 2009

Aprima Medical Software announces application hosting partnership with MednetwoRx

Aprima Medical Software (originally iMedica), a leading developer of electronic health record (EHR) and practice management (PM) systems for medical practices, today announced a reseller and application hosting partnership with Texas-based MednetwoRx.

30 Sep 2009

Ascent Healthcare Solutions selects TrackWise EQMS software to manage key quality processes

Sparta Systems, Inc., the maker of TrackWise® software and the market leader in enterprise quality and compliance solutions, today announced that Ascent Healthcare Solutions, Inc. a leader in delivering healthcare resource sustainability has selected its TrackWise Enterprise Quality Management System (EQMS) to streamline organizational quality practices and improve compliance with industry regulations.

30 Sep 2009

Lumenis to discuss different treatment options for laryngeal cancer at 2009 AAO-HNS

Lumenis Ltd., the world's largest medical laser company, announced today they will be focusing their attention at this year's AAO-HNS annual meeting in San Diego, California, on an educational event to discuss different treatment options for laryngeal cancer.

From Lumenis Inc. 30 Sep 2009

Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations

Caraco Pharmaceutical Laboratories, Ltd. announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities.

30 Sep 2009

SBIR grant from NIH to GenVec for metastatic cancer research

GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support the research of a new approach to treating metastatic cancer. Under this grant, valued at over $300,000, GenVec will investigate the hypothesis that the delivery of a specific gene will stimulate an antitumor response that could control cancer metastases.

30 Sep 2009

FDA approves Mylan Pharmaceuticals' Carbidopa and Levodopa tablets

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Carbidopa and Levodopa Tablets USP, 10mg/100mg, 25mg/100mg and 25mg/250 mg.

30 Sep 2009

ANXeBusiness highlights the importance of disaster plan readiness during H1N1

ANXeBusiness Corp., a leading provider of networking and security managed services, today issued advice for IT organizations on the importance of disaster plan readiness, proper employee education and preparation for organizations to maintain business continuity during the H1N1 influenza pandemic.

30 Sep 2009

US Farms, Nature's Best enter distribution partnership

US Farms, Inc. (Pink Sheets: USFM) today announced its distribution partnership with Nature's Best, Inc. and subsequent shipment of its Aloe365 Juice and US Farms Aloe Body Gel products. Nature's Best is one of the leading privately held health product distribution companies in the United States. Retailers can now place their orders for US Farms Aloe based products directly with Nature's Best in a timely, efficient manner.

30 Sep 2009

Phase III clinical trial results demonstrate effectiveness of spinosad suspension

ParaPRO, LLC announced today the results of two Phase III clinical studies published online this month in the journal Pediatrics (Pediatrics 2009; 124:e389-e395) which concluded that a spinosad suspension was significantly more effective in eliminating head lice (pediculosis capitis) than permethrin.

30 Sep 2009

Third version of Personal Wellness electronic Record released by The Quantum Group

The Quantum Group, Inc. announced that the third version of PWeRTM (Personal Wellness electronic RecordTM), PWeR 3.0, has deployed according to schedule. PWeR is the one patient, one record™ medical record platform that the Company believes is a relevant and real solution to meet current federal healthcare mandates and stimulus programs.

30 Sep 2009

Research study on teens who underwent laparoscopic bypass surgery

According to a recent study of clinical characteristics of teens who underwent laparoscopic Roux-en-Y gastric bypass surgery from 2002 until 2007, doctors may have a much narrower window of opportunity to reverse morbid obesity in teens than previously thought.

30 Sep 2009

Sun Pharma Global issues notice to Labopharm regarding its generic versions of Ryzolt

Labopharm Inc. today announced it has received notice from Sun Pharma Global FZE advising that Sun has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 100, 200 and 300 mg generic versions of Ryzolt(TM) (tramadol hydrochloride extended-release 100, 200 and 300 mg tablets) in the United States.

30 Sep 2009

Medical News

Immunocellular Therapeutics' pilot study can help in early cancer detection

Expression Analysis announces grants for research into complex diseases

CPM Marketing Group launches New Movers marketing program for hospitals and health systems

New treatment for chronic sinusitis from Summit Ear, Nose & Throat

Post Baccalaureate Premedical Program to begin in January 2010

Global use of biofuels expected to double by 2015

Omega-3 fatty acids prevent and slow age-related macular degeneration

Alliance Data, PDS sign multi-year agreement for patient financing and marketing services

Aprima Medical Software announces application hosting partnership with MednetwoRx

Ascent Healthcare Solutions selects TrackWise EQMS software to manage key quality processes

Lumenis to discuss different treatment options for laryngeal cancer at 2009 AAO-HNS

Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations

SBIR grant from NIH to GenVec for metastatic cancer research

FDA approves Mylan Pharmaceuticals' Carbidopa and Levodopa tablets

ANXeBusiness highlights the importance of disaster plan readiness during H1N1

US Farms, Nature's Best enter distribution partnership

Phase III clinical trial results demonstrate effectiveness of spinosad suspension

Third version of Personal Wellness electronic Record released by The Quantum Group

Research study on teens who underwent laparoscopic bypass surgery

Sun Pharma Global issues notice to Labopharm regarding its generic versions of Ryzolt

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News